A second endogenous' cannabinoid that modulates long-term potentiation

Nature

Volumn 388, Issue 6644, 1997, Pages 773-778

  Stella, Nephi ^a   Schweitzer, Paul ^b   Plomelli, Daniele ^a  

^a NEUROSCIENCES INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; CANNABIS;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANNABIS ADDICTION; COGNITION; DRUG RECEPTOR BINDING; EUPHORIA; LONG TERM POTENTIATION; MEMORY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACIDS; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CALCIUM; CANNABINOIDS; CELLS, CULTURED; DIGLYCERIDES; ELECTRIC STIMULATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCERIDES; HIPPOCAMPUS; LIGANDS; LONG-TERM POTENTIATION; NEURONS; POLYUNSATURATED ALKAMIDES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

ANIMALIA; CANNABIS; CANNABIS SATIVA; EUPHORIA;

EID: 0030870722     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/42015     Document Type: Article

References (30)

1. Herkenham, M. et al. Cannabinoid receptor localization in brain. Proc. Natl Acad. Sci. USA 87, 1932-1936 (1990).
2. Howlett, A. C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634 (1995).
3. Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258, 1946-1949 (1992).
4. Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol. 50, 83-90 (1995).
5. Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691 (1994).
6. Cadas, H., Gaillet, S., Beltramo, M., Venance, L. & Piomelli, D. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16, 3934-3942 (1996).
7. Beltramo, M. et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (in the press).
8. Desarnaud, F., Cadas, H. & Piomelli, D. Anandamide amidohydrolase activity in rat brain microsomes, J. Biol. Chem. 270, 6030-6035 (1995).
9. Ueda, N., Kurahashi, Y., Yamamoto, S. & Tokunaga, T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270, 23823-23827 (1995).
10. Cravatt, B. F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87 (1996).
11. Sugiura, T. et al. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylcthanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Eur. J. Biochem. 240, 53-62 (1996).
12. Schmid, P. C. et al. Corrigendum to: Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 385, 125 (1996).
13. Felder, C. C. et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393, 231-235 (1996).
14. Cadas, H., di Tomaso, E. & Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226-1242 (1997).
15. Smith, P. B. et al. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mouse. J. Pharmacol. Exp. Ther. 270, 219-227 (1994).
16. Evans, D. M., Lake, J. T., Johnson, M. R. & Hewlett, A. C. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J. Pharmacol. Exp. Ther. 268, 1271-1277 (1994).
17. Sugiura, T. et al. 2-arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97 (1995).
18. Bazan, N. G. Effects of ischemia and electroconvulsive shock on fatty acid pool in the brain. Biochim. Biophys. Acta. 218, 1-10 (1970).
19. Weiss, S. et al. Synaptogenesis of cultured striatal neurons in serum-free medium: a morphological and biochemical study. Proc. Natl Acad. Sci. USA 83, 2238-2242 (1986).
20. Brindley, D. N. in Biochemistry of Lipids and Membranes (eds Vance, D. E. & Vance, J. E.) 213-241 (Benjamin/Cummings, Menlo Park, 1985).
21. Prescott, S. M. & Majerus, P. W. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. J. Biol. Chem. 258, 764-769 (1983).
22. Farooqui, A. A., Taylor, W. A. & Horrocks, L. A. Characterization and solubilization of membrane bound diacyjglycerol lipases from bovine brain. Int. J. Biochem. 18, 991-997 (1986).
23. Jung, M. et al. Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A. J. Neurochem. 68, 402-409 (1997).
24. Nowicky, A. V. & Teyler, T. J. The modulation of long-term potentiation by Delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull. 19, 663-672 (1987).
25. Terranova, J.-P., Michaud, J.-C., Le Fur, G. & Soubrié, P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 576-579 (1995).
26. Heyser, C. J., Hampson, R. E. & Deadwyler, S. A. Effects of Delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J. Pharmacol. Exp. Ther. 264, 294-307 (1993).
27. Mallet, P. E. & Beninger, R. J. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav. Pharm. 7, 276-284 (1996).
28. Schmid, H. H. O., Schmid, P. C. & Natarajan, V. The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80, 133-142 (1996).
29. Stella, N., Pellerin, L. & Magistretti, P. Modulation of the glutamate-evoked release of arachidonic acid from mouse cortical neurons: involvement of a pH-sensitive membrane phospholipase A2. J. Neurosci. 15, 3307-3317 (1995).
30. Schweitzer, P., Madamba, S., Champagnat, J. & Siggins, G. R. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J. Neurosci. 13, 2033-2049 (1993).